new anti-cd20 antibodies for cll - are they better than rituximab?
Published 9 years ago • 1.8K plays • Length 21:17Download video MP4
Download video MP3
Similar videos
-
18:20
cll: do anti cd20 monoclonal antibodies add to novel agent outcomes?
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
7:04
anti-cd20 antibodies used in treating chronic lymphocytic leukemia
-
24:11
how should anti-cd20 monoclonal antibodies be utilized in cll?
-
26:34
chronic lymphocytic leukemia: mrd updates
-
8:24
cd-20 antibodies in chronic lymphocytic leukemia
-
1:21
the potential of adding anti-cd20 antibodies to acalabrutinib and venetoclax in cll
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
11:54
chronic lymphocytic leukemia - a treatable cancer | क्रोनिक लिम्फोसाइटिक ल्यूकेमिया
-
7:26
the truth about cll symptoms
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
22:08
role of chemotherapy in cll management
-
5:07
cd20-targeted antibodies with novel agents for cll
-
9:54
how cll impacts the immune system
-
1:21
emerging anti-cd20 monoclonal antibodies as first-line therapy in elderly cll
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
30:55
immune function in cll: what is wrong and why?
-
1:08:25
cll treatment new options, more hope
-
35:31
cll: btk inhibitors in hematologic oncology pathways - pathway-guided choices
-
21:13
breakthrough cll treatments: the latest advances in chronic lymphocytic leukemia | the patient story
-
1:03:50
new frontiers and emerging treatments for cll
-
16:58
chronic lymphocytic leukemia: treatment options for btki progressors